Cargando…
Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients
Background and purpose — Hip arthroplasty is one of the most performed surgeries in Sweden, and the rate of adverse events (AEs) is fairly high. All patients in publicly financed healthcare in Sweden are insured by the Mutual Insurance Company of Swedish County Councils (Löf). We assessed the propor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006721/ https://www.ncbi.nlm.nih.gov/pubmed/31615309 http://dx.doi.org/10.1080/17453674.2019.1677382 |
_version_ | 1783495200455262208 |
---|---|
author | Magnéli, Martin Unbeck, Maria Samuelsson, Bodil Rogmark, Cecilia Rolfson, Ola Gordon, Max Sköldenberg, Olof |
author_facet | Magnéli, Martin Unbeck, Maria Samuelsson, Bodil Rogmark, Cecilia Rolfson, Ola Gordon, Max Sköldenberg, Olof |
author_sort | Magnéli, Martin |
collection | PubMed |
description | Background and purpose — Hip arthroplasty is one of the most performed surgeries in Sweden, and the rate of adverse events (AEs) is fairly high. All patients in publicly financed healthcare in Sweden are insured by the Mutual Insurance Company of Swedish County Councils (Löf). We assessed the proportion of patients that sustained a major preventable AE and filed an AE claim to Löf. Patients and methods — We performed retrospective record review using the Global Trigger Tool to identify AEs in a Swedish multi-center cohort consisting of 1,998 patients with a total or hemi hip arthroplasty. We compared the major preventable AEs with all patient-reported claims to Löf from the same cohort and calculated the proportion of filed claims. Results — We found 1,066 major preventable AEs in 744 patients. Löf received 62 claims for these AEs, resulting in a claim proportion of 8%. 58 of the 62 claims were accepted by Löf and received compensation. The claim proportion was 13% for the elective patients and 0.3% for the acute patients. The most common AE for filing a claim was periprosthetic joint infection; of the 150 infections found 37 were claimed. Interpretation — The proportion of filed claims for major preventable AEs is very low, even for obvious and serious AEs such as periprosthetic joint infection. |
format | Online Article Text |
id | pubmed-7006721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-70067212020-02-20 Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients Magnéli, Martin Unbeck, Maria Samuelsson, Bodil Rogmark, Cecilia Rolfson, Ola Gordon, Max Sköldenberg, Olof Acta Orthop Hip Background and purpose — Hip arthroplasty is one of the most performed surgeries in Sweden, and the rate of adverse events (AEs) is fairly high. All patients in publicly financed healthcare in Sweden are insured by the Mutual Insurance Company of Swedish County Councils (Löf). We assessed the proportion of patients that sustained a major preventable AE and filed an AE claim to Löf. Patients and methods — We performed retrospective record review using the Global Trigger Tool to identify AEs in a Swedish multi-center cohort consisting of 1,998 patients with a total or hemi hip arthroplasty. We compared the major preventable AEs with all patient-reported claims to Löf from the same cohort and calculated the proportion of filed claims. Results — We found 1,066 major preventable AEs in 744 patients. Löf received 62 claims for these AEs, resulting in a claim proportion of 8%. 58 of the 62 claims were accepted by Löf and received compensation. The claim proportion was 13% for the elective patients and 0.3% for the acute patients. The most common AE for filing a claim was periprosthetic joint infection; of the 150 infections found 37 were claimed. Interpretation — The proportion of filed claims for major preventable AEs is very low, even for obvious and serious AEs such as periprosthetic joint infection. Taylor & Francis 2019-10-16 /pmc/articles/PMC7006721/ /pubmed/31615309 http://dx.doi.org/10.1080/17453674.2019.1677382 Text en © 2019 The Author(s). Published by Taylor & Francis on behalf of the Nordic Orthopedic Federation https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Hip Magnéli, Martin Unbeck, Maria Samuelsson, Bodil Rogmark, Cecilia Rolfson, Ola Gordon, Max Sköldenberg, Olof Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients |
title | Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients |
title_full | Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients |
title_fullStr | Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients |
title_full_unstemmed | Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients |
title_short | Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients |
title_sort | only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a swedish multi-center cohort study on 1,998 patients |
topic | Hip |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006721/ https://www.ncbi.nlm.nih.gov/pubmed/31615309 http://dx.doi.org/10.1080/17453674.2019.1677382 |
work_keys_str_mv | AT magnelimartin only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients AT unbeckmaria only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients AT samuelssonbodil only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients AT rogmarkcecilia only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients AT rolfsonola only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients AT gordonmax only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients AT skoldenbergolof only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients |